MedPath

BI-691751

Generic Name
BI-691751

Multiple Rising Oral Doses of BI 691751 in Healthy Male Subjects

Phase 1
Terminated
Conditions
Healthy
Interventions
Drug: Placebo
First Posted Date
2014-05-28
Last Posted Date
2016-02-29
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
18
Registration Number
NCT02148107
Locations
🇩🇪

1334.2.1 Boehringer Ingelheim Investigational Site, Berlin, Germany

Interaction of BI 691751 With Itraconazole

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2014-01-24
Last Posted Date
2015-12-16
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
20
Registration Number
NCT02044393
Locations
🇩🇪

1334.10.1 Boehringer Ingelheim Investigational Site, Biberach, Germany

Safety of Single Rising Doses and Relative Bioavailability of BI 691751

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Placebo
First Posted Date
2013-05-01
Last Posted Date
2016-06-27
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
81
Registration Number
NCT01843972
Locations
🇩🇪

1334.1.1 Boehringer Ingelheim Investigational Site, Biberach, Germany

© Copyright 2025. All Rights Reserved by MedPath